Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
Cancers | Free Full-Text | Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies | Prostate Cancer and Prostatic Diseases
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy - Hartrampf - 2022 - The Prostate - Wiley Online Library
Test May Show Whether to Treat Prostate Cancer with Hormones - NCI
PSA Test stock photo. Image of cell, prostate, medical - 54017994
Descriptive analysis of total PSA according to age. | Download Table
Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy? | Journal of Clinical Pathology
Tissue PSA distribution across the prostate gland at t = 0.5 y, tumor... | Download Scientific Diagram
Clinical Case Discussions - Rising PSA 18 Months Post RP and Timing of Radiotherapy | Rising PSA 18 months post-RP & timing of radiotherapy. Ashley Ross, MD, PhD Northwestern University Feinberg School
Three-month early change in prostate-specific antigen levels as a predictive marker for overall survival during hormonal therapy for metastatic hormone-sensitive prostate cancer | BMC Research Notes | Full Text
Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
SciELO - Brasil - PSA kinetics before 40 years of age PSA kinetics before 40 years of age
Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy | PLOS ONE
PSA Testing | ZERO Prostate Cancer
Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
MRI-Targeted or Standard Biopsy in Prostate Cancer Screening | NEJM
